Inventprise Press Release Archive

Inventprise Completes Vaccination of Participants in a Phase 2 Dose Ranging Study of its 25 Valent Pneumococcal Vaccine Candidate
New Inventprise Pneumococcal Vaccine Enters Phase 1/2 Clinical Evaluation
Inventprise Inaugurates Manufacturing Facility for High-Capacity Supply of Pneumococcal Conjugate Vaccines
Inventprise Receives $30M, Appoints New CEO and Expands Corporate Board
Inventprise Announces Investment of up to $90 Million to Advance its 25 Valent Pneumococcal Conjugate Vaccine Candidate into Proof-of-Concept Clinical Trials